Page last updated: 2024-10-26

valproic acid and Alcohol Problem

valproic acid has been researched along with Alcohol Problem in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"Subjects were diagnosed with either major depressive disorder (MDD) or bipolar depression."2.55Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. ( Luckenbaugh, DA; Niciu, MJ; Pennybaker, SJ; Zarate, CA, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pennybaker, SJ1
Niciu, MJ1
Luckenbaugh, DA1
Zarate, CA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist[NCT00088699]Phase 1/Phase 267 participants (Actual)Interventional2004-07-26Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

MADRS Score - Baseline

Antidepressant effects were assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS). It is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. (NCT00088699)
Timeframe: Baseline

Interventionunits on a scale (Mean)
Ketamine - Healthy Volunteers1.17
Placebo - Healthy Volunteers1.48
Ketamine - MDD Patients33.83
Placebo - MDD Patients31.82

MADRS Score - Day 1 Following Intervention

Antidepressant effects were assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS). It is a ten-item diagnostic questionnaire which psychiatrists use to measure the severity of depressive episodes. Higher MADRS score indicates more severe depression, and each item yields a score of 0 to 6. The overall score ranges from 0 to 60. (NCT00088699)
Timeframe: Day 1

Interventionunits on a scale (Mean)
Ketamine - Healthy Volunteers2.45
Placebo - Healthy Volunteers0.67
Ketamine - MDD Patients23.73
Placebo - MDD Patients30.68

Reviews

1 review available for valproic acid and Alcohol Problem

ArticleYear
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
    Journal of affective disorders, 2017, Jan-15, Volume: 208

    Topics: Adult; Alcohol-Related Disorders; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Majo

2017